| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/25/2005 | CN1202815C Delayed-action form of administration containing tramadol saccharinate |
| 05/25/2005 | CN1202757C Pear, peach and apricot honey candy for prevention and cure of cough and asthma |
| 05/24/2005 | US6897237 MMP-12 inhibitors |
| 05/24/2005 | US6897232 Activate soluble guanylate cyclase; for use treating cardiovascular disorders, erectile dysfunction, diabetes, and cirrhosis of the liver, kidney disorders, and learning disability |
| 05/24/2005 | US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole |
| 05/24/2005 | US6897229 Use of PDE4 inhibitor N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide, salts or its N-oxide with PDE3 inhibitor for treatment of obstructions of bronchi |
| 05/24/2005 | US6897227 Prodrugs of proton pump inhibitors |
| 05/24/2005 | US6897226 NK-1 receptor active amine oxide prodrugs |
| 05/24/2005 | US6897221 Urea substituted imidazoquinolines |
| 05/24/2005 | US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents |
| 05/24/2005 | US6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | US6897206 Combinations for the treatment of inflammatory disorders |
| 05/24/2005 | US6897203 Polysaccharidic esters of retinoic acid |
| 05/24/2005 | US6897044 Drugs for treatment of cancer/autoimmune disorders; apoptosis promoters |
| 05/24/2005 | US6896906 A spray dried powder prepared by aerosolization; superior chemical and physical stability over their solution counterparts; inhaleable powder |
| 05/24/2005 | CA2210708C Tricyclic vasopressin antagonists |
| 05/19/2005 | WO2005044268A1 Preparation of pharmaceutical salts of [1, 4] - bipiperidine |
| 05/19/2005 | WO2005014576A8 Isoquinolinone derivative, process for producing the same and use thereof |
| 05/19/2005 | WO2004106934A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 05/19/2005 | US20050107611 For use as adenosine receptor ligands; immunostimulants; contraceptives |
| 05/19/2005 | US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection |
| 05/19/2005 | US20050107474 Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents |
| 05/19/2005 | US20050107462 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/19/2005 | US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors |
| 05/19/2005 | US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 05/19/2005 | US20050107429 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107418 Macrolides |
| 05/19/2005 | US20050107413 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 05/19/2005 | US20050107410 Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 05/19/2005 | US20050107394 Novel use of selective pde5 inhibitors |
| 05/19/2005 | US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders |
| 05/19/2005 | US20050107375 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease |
| 05/19/2005 | US20050107330 Drug mixture contains a sympathomimetic selected from the group consisting oxymetazoline, xylometazoline, tramazoline, tetryzoline and naphazoline, and glycosaminoglycan of hyaluronic acid; synergistic effect; vasoconstrictor action, detumescent action on the nose mucous membrane |
| 05/19/2005 | US20050107306 Treatment of respiratory disease associated with matrix metalloproteases by inhalation of synthetic matrix metalloprotease inhibitors |
| 05/19/2005 | US20050107291 Compositions and methods for treating or preventing diseases of body passageways |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders |
| 05/19/2005 | US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | US20050106220 Administering gamma-aminobutyric acid receptor antagonist |
| 05/19/2005 | US20050106212 Using electrochemical mixture of metal compound and bioactive material; contacting substrate |
| 05/19/2005 | US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof |
| 05/19/2005 | US20050106128 Novel methods of treatment and deliver modes |
| 05/19/2005 | DE10148828B4 Modulation der Expression STAT-1-abhängiger Gene Modulating the expression of STAT-1-dependent genes |
| 05/19/2005 | CA2545157A1 Disinfecting composition and methods of making and using same |
| 05/19/2005 | CA2544845A1 Preparation of pharmaceutical salts of [1, 4] - bipiperidine |
| 05/19/2005 | CA2543199A1 Use of crth2 antagonist compounds in therapy |
| 05/18/2005 | EP1530586A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/18/2005 | EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 05/18/2005 | EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 05/18/2005 | EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530471A1 Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs |
| 05/18/2005 | EP1530466A2 Use of lck inhibitor for treatment of immunologic diseases |
| 05/18/2005 | EP1530464A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/18/2005 | EP1436381B1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | CN1617865A Phenylalkynes |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 05/18/2005 | CN1617855A Inhibitors of cytosolic phospholipase A2 |
| 05/18/2005 | CN1617743A New pharmaceutical combinations for nos inhibitors |
| 05/18/2005 | CN1617739A Methods and compositions for treating lesions of the respiratory epithelium |
| 05/18/2005 | CN1617724A Neurotransmitter balance chemotherapy |
| 05/18/2005 | CN1617722A Nicotin-or isonicotin benzothiazole derivatives |
| 05/18/2005 | CN1617721A Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 05/18/2005 | CN1617715A Treating muscle wasting with selective androgen receptor modulators |
| 05/18/2005 | CN1616670A 感染性克隆 Infectious clone |
| 05/18/2005 | CN1616485A SARS coronavirus structure protein ORF3 and its use |
| 05/18/2005 | CN1616459A Adenosine derivatives |
| 05/18/2005 | CN1616422A Disulfide derivatives useful for treating allergic diseases |
| 05/18/2005 | CN1616110A SARS yeast crossbreeding vaccine and its preparing method |
| 05/18/2005 | CN1616057A Yujin freeze-dried powder injection and its preparing method |
| 05/18/2005 | CN1616055A Medicinal composition containing Aerican ginseng and tuber of dwarf lily turf effective part and its preparing method |
| 05/18/2005 | CN1616051A Powder injection for intravenous injection and its preparing method |
| 05/18/2005 | CN1616050A Yinhuang oral liquor and its producing process |
| 05/18/2005 | CN1616049A Intravenous transfusion for treating infection of upper respiratory tract and its preparing method |
| 05/18/2005 | CN1616047A Anti-inflammatory and keeping adverse energy downwards capsule for treating asthma, pulmonary emphysema and SARS |
| 05/18/2005 | CN1616042A Chinese medicine composition for treating chronic bronchitis |
| 05/18/2005 | CN1616038A Wild chrysanthemum flower freeze-dried powder injection and its preparing method |
| 05/18/2005 | CN1616032A Process for preparing granular preparation for treating pharyngeal disease and method for controlling quality |
| 05/18/2005 | CN1616015A Medicine for treating asthma disease and its preparing method |
| 05/18/2005 | CN1616002A Oral administration or lozenge medicine for treating acute pharyngitis and acute tonsillitis |
| 05/18/2005 | CN1615995A Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method |
| 05/18/2005 | CN1615984A Fast acting rhinitis medicine |
| 05/18/2005 | CN1615960A Medicine for treating lung disease, preparing method for medicine and preparation |
| 05/18/2005 | CN1615945A Chinese medicine recipe for treating tracheopathy |
| 05/18/2005 | CN1615943A Chenese medicine recipe for treating throat disease |
| 05/18/2005 | CN1615942A Rhinitis treating medicinal cream |
| 05/18/2005 | CN1615923A Medicinal composition and its preparing method and use |
| 05/18/2005 | CN1615918A Chinese medicine effervescent tablet and its preparing method |
| 05/18/2005 | CN1615873A Azaindoles compound |
| 05/18/2005 | CN1615858A Compound bergenin dripping pill and its preparing method |